Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALPXT96 for Sleep Quality in Chronic Non-cancer Pain
NCT02232256Phase 3Withdrawn
- Sponsor
- 9305-9954 Quebec
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- PE (Plant Extract), Dietary Supplement
- Countries
- 1
01
Overview
A Phase 3 trial of CALPXT96 in Insomnia, sponsored by 9305-9954 Quebec. Planned start Dec 2015; status: withdrawn.
02
Drugs
CALPXT96
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02232256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232256.